Skip to content

Clinical trials

Phase 3 Brain Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 3 Country / region: France Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20041
20061
20081
20092
20101
20111
20131
20151
20164
20211
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated3
Active, not recruiting2
Not yet recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Assistance Publique - Hôpitaux de Paris2
Bristol-Myers Squibb2
NovoCure Ltd.2
Spectrum Pharmaceuticals, Inc2
AbbVie1
Celldex Therapeutics1
Centre Paul Strauss1
HUYABIO International, LLC.1
Institut Cancerologie de l'Ouest1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms24
Glioblastoma8
Neoplasm Metastasis5
Glioma4
Astrocytoma3
Breast Neoplasms3
Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Gliosarcoma2
Melanoma2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.